Abstract: The invention relates to acyl-3-carboxyphenylurea derivatives and to their physiologically tolerated salts and physiologically functional derivatives. The invention relates to compounds of formula I, in which the radicals have the given meanings, and to their physiologically tolerated salts and processes for preparing them. The compounds are, for example, suitable for use as antidiabetics.

Abstract: N-Benzoylureidocinnamic acid derivatives, processes for preparing them and their use The invention relates to N-benzoylureidocinnamic acid derivatives and to their physiologically tolerated salts and physiologically functional derivatives. The invention thus relates to compounds of formula I, in which the radicals have the given meanings, and to their physiologically tolerated salts and processes for preparing them. The compounds are, for example, suitable for use as antidiabetic agents.

Abstract: An emission remediation system and methods are disclosed. An emission remediation indicator associated with an emission-related activity is vended. At least a portion of proceeds from the vending of remediation indicators is aggregated into a fund. A remediation activity by an emission producer is funded using the aggregate fund.

Abstract: Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments The invention relates to cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.

Abstract: The invention relates to heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.

Abstract: 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments The invention relates to 7-phenylamino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.

Abstract: The invention relates to compounds of the formula I in which the radicals are defined as specified, and also to their physiologically tolerated salts. The compounds are suitable, for example, as medicaments for preventing and treating type 2 diabetes.

Abstract: The invention is based on the concept of providing a digital data transmission of the fuze-timing data into a fuze-timable ammunition unit, for example with an HDB-3 (High-Density Bipolar) transmission code and voltage modulation. As is known from asynchronous data transmission, a start byte and a stop byte are respectively positioned in front of and behind the HDB-3 code, and are therefore components of thee fuze-timing data. The fuze-timing time is transmitted numerically as a data byte between the start and stop bytes. Accordingly, the ammunition unit (3) includes fuze-timing electronics (4), which comprise a (voltage) demodulator (30), a (current) modulator (31) and a microprocessor (32) having an RC-oscillator cycle counter (32.1), an RC oscillator (33), a fuze-timing counter (34) and an actuator end stage (36). A firing sensor (35) serves as the fuze-timing-time triggering element at the start of the flight phase.

Abstract: The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and process for their preparation are described. The compounds are suitable, for example, for treating type II diabetes.

Abstract: Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use

Abstract: Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments

Abstract: The invention relates to heterocyclically substituted benzoylureas and also to their physiologically tolerated salts and physiologically functional derivatives.

Abstract: The invention relates to N-benzoylureidocinnamic acid derivatives and to their physiologically tolerated salts and physiologically functional derivatives.

Abstract: The invention relates to urea- and urethane-substituted acylureas and to their physiologically tolerated salts and physiologically functional derivatives.

Abstract: The invention relates to acyl-4-carboxyphenylurea derivatives and to their physiologically tolerated salts and physiologically functional derivatives.

Abstract: The invention relates to acyl-3-carboxyphenylurea derivatives and to their physiologically tolerated salts and physiologically functional derivatives.

Abstract: The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives.

Abstract: Method for interference suppression by means of a quality-adjustable bandpass filter in a receiver circuit for carrier-modulated received signals (SIN), in which the bandpass filtered received signal (Bout) is demodulated, and a switching process is triggered with the demodulated received signal (Dout). Known receiver circuits, however, have the disadvantage, due to small dimensions of the circuit surface area, that interferences, for example in the form of oscillator oscillations due to capacitive couplings, are caused by switching processes in the output portion of the receiver, especially by driving transistors. These interferences cannot be eliminated by an amplifier regulation provided in the circuit. According to the invention, such internal or self-induced interferences or disturbances are eliminated in that a quality reduction of the bandpass filter is correlated with the switching process that causes the interference.

Abstract: The invention is based on the concept of providing a digital data transmission of the fuze-timing data into a fuze-timable ammunition unit, for example with an HDB-3 (High-Density Bipolar) transmission code and voltage modulation. As is known from asynchronous data transmission, a start byte and a stop byte are respectively positioned in front of and behind the HDB-3 code, and are therefore components of the fuze-timing data. The fuze-timing time is transmitted numerically as a data byte between the start and stop bytes.

Abstract: The invention relates to a method according to which a portal site (10) for a user is automatically generated on a terminal (12). A request profile (16) of the respective user, terminal-specific parameters (18) and services which are available for the terminal (12) are detected. The selected services are subsequently allocated. In another embodiment, a portal site is automatically generated.